{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:07:21Z","timestamp":1791360441261,"version":"4.3.1"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Substance use disorders (SUDs) are underrecognized in primary care, where structured clinical interviews are often infeasible. A brief, standardized substance use symptom checklist could help clinicians assess SUD.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate the psychometric properties of the Substance Use Symptom Checklist (hereafter symptom checklist) used in primary care among patients reporting daily cannabis use and\/or other drug use as part of population-based screening and assessment.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study was conducted among adult primary care patients who completed the symptom checklist during routine care between March 1, 2015, and March 1, 2020, at an integrated health care system. Data analysis was conducted from June 1, 2021, to May 1, 2022.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The symptom checklist included 11 items corresponding to SUD criteria in the Diagnostic and Statistical Manual for Mental Disorders<\/jats:italic> (Fifth Edition) (DSM-5<\/jats:italic>). Item response theory (IRT) analyses tested whether the symptom checklist was unidimensional and reflected a continuum of SUD severity and evaluated item characteristics (discrimination and severity). Differential item functioning analyses examined whether the symptom checklist performed similarly across age, sex, race, and ethnicity. Analyses were stratified by cannabis and\/or other drug use.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 23\u202f304 screens were included (mean [SD] age, 38.2 [5.6] years; 12\u202f554 [53.9%] male patients; 17\u202f439 [78.8%] White patients; 20\u202f393 [87.5%] non-Hispanic patients). Overall, 16\u202f140 patients reported daily cannabis use only, 4791 patients reported other drug use only, and 2373 patients reported both daily cannabis and other drug use. Among patients with daily cannabis use only, other drug use only, or both daily cannabis and other drug use, 4242 (26.3%), 1446 (30.2%), and 1229 (51.8%), respectively, endorsed 2 or more items on the symptom checklist, consistent with DSM-5<\/jats:italic> SUD. For all cannabis and drug subsamples, IRT models supported the unidimensionality of the symptom checklist, and all items discriminated between higher and lower levels of SUD severity. Differential item functioning was observed for some items across sociodemographic subgroups but did not result in meaningful change (&amp;lt;1 point difference) in the overall score (0-11).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study, a symptom checklist, administered to primary care patients who reported daily cannabis and\/or other drug use during routine screening, discriminated SUD severity as expected and performed well across subgroups. Findings support the clinical utility of the symptom checklist for standardized and more complete SUD symptom assessment to help clinicians make diagnostic and treatment decisions in primary care.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.16283","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:31:59Z","timestamp":1685115119000},"page":"e2316283","source":"Crossref","is-referenced-by-count":28,"title":["Psychometric Performance of a Substance Use Symptom Checklist to Help Clinicians Assess Substance Use Disorder in Primary Care"],"prefix":"10.1001","volume":"6","author":[{"given":"Theresa E.","family":"Matson","sequence":"first","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle"},{"name":"Health Services Research & Development Center for Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Hallgren","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle"},{"name":"Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen T.","family":"Lapham","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malia","family":"Oliver","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for the Clinical Trials Network, National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle"},{"name":"Health Services Research & Development Center for Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute, Seattle"},{"name":"Department of Health Systems and Population Health, University of Washington School of Public Health, Seattle"},{"name":"Department of Medicine, University of Washington School of Medicine, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"9810","key":"zoi230496r2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease.","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"zoi230496r5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11606-020-05650-3","article-title":"Routine assessment of symptoms of substance use disorders in primary care: prevalence and severity of reported symptoms.","volume":"35","author":"Sayre","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"7","key":"zoi230496r6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7205\/MILMED-D-12-00052","article-title":"The underdiagnosis of cannabis use disorders and other axis-I disorders among military veterans within VHA.","volume":"177","author":"Bonn-Miller","year":"2012","journal-title":"Mil Med"},{"issue":"4","key":"zoi230496r7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1037\/a0027622","article-title":"Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009.","volume":"9","author":"Bonn-Miller","year":"2012","journal-title":"Psychol Serv"},{"key":"zoi230496r8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2019.11.008","article-title":"Prevalence of documented alcohol and opioid use disorder diagnoses and treatments in a regional primary care practice-based research network.","volume":"110","author":"Hallgren","year":"2020","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"zoi230496r9","doi-asserted-by":"publisher","first-page":"e2219651","DOI":"10.1001\/jamanetworkopen.2022.19651","article-title":"Comparison of substance use disorder diagnosis rates from electronic health record data with substance use disorder prevalence rates reported in surveys across sociodemographic groups in the Veterans Health Administration.","volume":"5","author":"Williams","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi230496r10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"zoi230496r11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III.","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"5","key":"zoi230496r12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/phar.2016.36.issue-5","article-title":"Treatment of cannabis use disorder: current science and future outlook.","volume":"36","author":"Sherman","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"6","key":"zoi230496r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: a systematic review of reviews.","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"zoi230496r14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: a scoping review.","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"issue":"22","key":"zoi230496r15","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.8020","article-title":"Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement.","volume":"323","author":"Krist","year":"2020","journal-title":"JAMA"},{"issue":"10","key":"zoi230496r16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/M16-0317","article-title":"Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) tool for substance use screening in primary care patients.","volume":"165","author":"McNeely","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi230496r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2004.03.012","article-title":"Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.","volume":"27","author":"Forman","year":"2004","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi230496r19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cbpra.2014.01.010","article-title":"Using measurement-based care to enhance any treatment.","volume":"22","author":"Scott","year":"2015","journal-title":"Cogn Behav Pract"},{"issue":"8","key":"zoi230496r20","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/add.v114.8","article-title":"Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?","volume":"114","author":"Marsden","year":"2019","journal-title":"Addiction"},{"key":"zoi230496r21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jsat.2015.01.008","article-title":"The psychometric properties of the Drug Use Disorders Identification Test (DUDIT): a review of recent research.","volume":"53","author":"Hildebrand","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi230496r22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A comprehensive review of the psychometric properties of the Drug Abuse Screening Test.","volume":"32","author":"Yudko","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"zoi230496r23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.drugalcdep.2019.04.015","article-title":"Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: an evaluation in three pilot sites.","volume":"201","author":"Richards","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi230496r24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-018-0795-9","article-title":"Study protocol: a cluster-randomized trial implementing Sustained Patient-Centered Alcohol-Related Care (SPARC trial).","volume":"13","author":"Glass","year":"2018","journal-title":"Implement Sci"},{"issue":"8","key":"zoi230496r25","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/add.v114.8","article-title":"Making measurement-based care for addictions a reality in primary care.","volume":"114","author":"Bradley","year":"2019","journal-title":"Addiction"},{"issue":"9","key":"zoi230496r26","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/ijerph14091030","article-title":"Evaluation of a pilot implementation to integrate alcohol-related care within primary care.","volume":"14","author":"Bobb","year":"2017","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"zoi230496r27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/hesr.v55.6","article-title":"Costs of using evidence-based implementation strategies for behavioral health integration in a large primary care system.","volume":"55","author":"Yeung","year":"2020","journal-title":"Health Serv Res"},{"issue":"8","key":"zoi230496r28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamainternmed.2019.7335","article-title":"Screening for drug use in primary care: practical implications of the new USPSTF recommendation.","volume":"180","author":"Bradley","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"9","key":"zoi230496r29","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1360-0443.2002.00185.x","article-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility.","volume":"97","author":"WHO ASSIST Working Group","year":"2002","journal-title":"Addiction"},{"issue":"11","key":"zoi230496r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.39772","article-title":"Validity of the Single-Item Screen-Cannabis (SIS-C) for cannabis use disorder screening in routine care.","volume":"5","author":"Matson","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi230496r31","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1176\/appi.ajp.2013.12060782","article-title":"DSM-5 criteria for substance use disorders: recommendations and rationale.","volume":"170","author":"Hasin","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"6","key":"zoi230496r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i06","article-title":"mirt: A multidimensional item response theory package for the R environment.","volume":"48","author":"Chalmers","year":"2012","journal-title":"J Stat Softw"},{"issue":"10","key":"zoi230496r35","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41386-020-00950-y","article-title":"Addiction as a brain disease revised: why it still matters, and the need for consilience.","volume":"46","author":"Heilig","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"zoi230496r36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcps.2009.09.003","article-title":"Structural equations modeling: fit indices, sample size, and advanced topics.","volume":"20","author":"Iacobucci","year":"2010","journal-title":"J Consum Psychol"},{"issue":"3","key":"zoi230496r37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1207\/S15327906347-387","article-title":"Factor analysis of ordinal variables: a comparison of three approaches.","volume":"36","author":"J\u00f6reskog","year":"2001","journal-title":"Multivariate Behav Res"},{"issue":"6","key":"zoi230496r38","first-page":"597","article-title":"Item response theory and confirmatory factor analysis: complementary approaches for scale development.","volume":"18","author":"Bean","year":"2021","journal-title":"J Evid Based Soc Work"},{"issue":"1","key":"zoi230496r40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272431613511332","article-title":"Practical guide to conducting an item response theory analysis.","volume":"34","author":"Toland","year":"2014","journal-title":"J Early Adolesc"},{"issue":"1","key":"zoi230496r41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40271-013-0041-0","article-title":"An introduction to item response theory for patient-reported outcome measurement.","volume":"7","author":"Nguyen","year":"2014","journal-title":"Patient"},{"issue":"9","key":"zoi230496r42","doi-asserted-by":"publisher","first-page":"II28","DOI":"10.1097\/00005650-200009002-00007","article-title":"Item response theory and health outcomes measurement in the 21st century.","volume":"38","author":"Hays","year":"2000","journal-title":"Med Care"},{"issue":"1","key":"zoi230496r43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0013164415584576","article-title":"It might not make a big DIF: improved differential test functioning statistics that account for sampling variability.","volume":"76","author":"Chalmers","year":"2016","journal-title":"Educ Psychol Meas"},{"issue":"8","key":"zoi230496r44","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11606-021-07038-3","article-title":"Practical assessment of alcohol use disorder in routine primary care: performance of an alcohol symptom checklist.","volume":"37","author":"Hallgren","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"2","key":"zoi230496r45","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1207\/S15328007SEM0902_5","article-title":"Evaluating goodness-of-fit indexes for testing measurement invariance.","volume":"9","author":"Cheung","year":"2002","journal-title":"Struct Equ Modeling"},{"key":"zoi230496r46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.addbeh.2015.10.015","article-title":"Psychometric modeling of abuse and dependence symptoms across six illicit substances indicates novel dimensions of misuse.","volume":"53","author":"Clark","year":"2016","journal-title":"Addict Behav"},{"issue":"3","key":"zoi230496r47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.drugalcdep.2008.10.009","article-title":"The role of cannabis use within a dimensional approach to cannabis use disorders.","volume":"100","author":"Compton","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"zoi230496r48","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/add.2013.108.issue-10","article-title":"Measurement invariance of DSM-IV alcohol, marijuana and cocaine dependence between community-sampled and clinically overselected studies.","volume":"108","author":"Derringer","year":"2013","journal-title":"Addiction"},{"issue":"6","key":"zoi230496r49","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/add.2007.102.issue-6","article-title":"Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.","volume":"102","author":"Gillespie","year":"2007","journal-title":"Addiction"},{"issue":"9","key":"zoi230496r50","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1017\/S0033291707000396","article-title":"Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"37","author":"Lynskey","year":"2007","journal-title":"Psychol Med"},{"issue":"6","key":"zoi230496r51","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/add.2011.106.issue-6","article-title":"The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.","volume":"106","author":"Piontek","year":"2011","journal-title":"Addiction"},{"issue":"1-2","key":"zoi230496r52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.09.004","article-title":"Analyses related to the development of DSM-5 criteria for substance use related disorders: 1. toward amphetamine, cocaine and prescription drug use disorder continua using item response theory.","volume":"122","author":"Saha","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi230496r53","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mpr.v21.2","article-title":"A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.","volume":"21","author":"Wu","year":"2012","journal-title":"Int J Methods Psychiatr Res"},{"key":"zoi230496r54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jpsychires.2016.05.007","article-title":"Exploring the latent trait of opioid use disorder criteria among frequent nonmedical prescription opioid users.","volume":"80","author":"Castaldelli-Maia","year":"2016","journal-title":"J Psychiatr Res"},{"issue":"3","key":"zoi230496r55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000369338","article-title":"Latent class analysis of DSM-5 criteria for opioid use disorders: results from the Iranian National Survey on Mental Health.","volume":"21","author":"Tarrahi","year":"2015","journal-title":"Eur Addict Res"},{"issue":"3","key":"zoi230496r56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.addbeh.2009.10.009","article-title":"An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.","volume":"35","author":"Wu","year":"2010","journal-title":"Addict Behav"},{"issue":"9","key":"zoi230496r57","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.addbeh.2011.04.006","article-title":"Dimensionality of hallucinogen and inhalant\/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition.","volume":"36","author":"Kerridge","year":"2011","journal-title":"Addict Behav"},{"issue":"4","key":"zoi230496r58","first-page":"260","article-title":"Item response theory analysis to assess dimensionality of substance use disorder abuse and dependence symptoms.","volume":"6","author":"Kirisci","year":"2016","journal-title":"Int J Pers Cent Med"},{"issue":"4","key":"zoi230496r59","doi-asserted-by":"publisher","first-page":"607","DOI":"10.15288\/jsad.2010.71.607","article-title":"Item response theory analysis of DSM-IV criteria for inhalant-use disorders in adolescents.","volume":"71","author":"Perron","year":"2010","journal-title":"J Stud Alcohol Drugs"},{"key":"zoi230496r60","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.3389\/fpsyg.2019.02209","article-title":"An item response theory analysis of DSM-5 heroin use disorder in a clinical sample of Chinese adolescents.","volume":"10","author":"Yang","year":"2019","journal-title":"Front Psychol"},{"issue":"2","key":"zoi230496r61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/chi.0b013e31815cd9f2","article-title":"Item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents.","volume":"47","author":"Hartman","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"zoi230496r62","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1037\/0021-843X.115.4.807","article-title":"Item response theory analysis of diagnostic criteria for alcohol and cannabis use disorders in adolescents: implications for DSM-V.","volume":"115","author":"Martin","year":"2006","journal-title":"J Abnorm Psychol"},{"issue":"9","key":"zoi230496r63","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/add.13421","article-title":"Is khat use disorder a valid diagnostic entity?","volume":"111","author":"Duresso","year":"2016","journal-title":"Addiction"},{"key":"zoi230496r64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.drugalcdep.2013.10.010","article-title":"Item response theory analyses of DSM-IV and DSM-5 stimulant use disorder criteria in an American Indian community sample.","volume":"135","author":"Gilder","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"zoi230496r65","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108036","article-title":"Item response theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants: how much is craving special?","volume":"212","author":"Kervran","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi230496r66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jpsychires.2011.12.002","article-title":"Alcohol and drug dependence symptom items as brief screeners for substance use disorders: results from the Clinical Trials Network.","volume":"46","author":"Wu","year":"2012","journal-title":"J Psychiatr Res"},{"issue":"3","key":"zoi230496r67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.15288\/jsad.2009.70.414","article-title":"An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study.","volume":"70","author":"Wu","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"issue":"3","key":"zoi230496r68","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.drugalcdep.2009.01.018","article-title":"The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study.","volume":"103","author":"Wu","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi230496r69","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1037\/0021-843X.113.1.72","article-title":"An application of item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV.","volume":"113","author":"Langenbucher","year":"2004","journal-title":"J Abnorm Psychol"},{"issue":"1-2","key":"zoi230496r70","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugalcdep.2011.09.005","article-title":"Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.","volume":"122","author":"Hasin","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi230496r71","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1037\/abn0000678","article-title":"Does crude measurement contribute to observed unidimensionality of psychological constructs? a demonstration with DSM-5 alcohol use disorder.","volume":"130","author":"Watts","year":"2021","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"zoi230496r72","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.cpr.2007.08.002","article-title":"Screening psychiatric patients for illicit drug use disorders and problems.","volume":"28","author":"Tiet","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"zoi230496r73","first-page":"171","article-title":"Item response theory for measurement validity.","volume":"26","author":"Yang","year":"2014","journal-title":"Shanghai Arch Psychiatry"},{"issue":"4","key":"zoi230496r74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1037\/1082-989X.9.4.466","article-title":"An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data.","volume":"9","author":"Flora","year":"2004","journal-title":"Psychol Methods"},{"key":"zoi230496r4","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed"},{"key":"zoi230496r33","volume-title":"The Basics of Item Response Theory","author":"Baker","year":"2001"},{"key":"zoi230496r39","doi-asserted-by":"crossref","DOI":"10.4324\/9780203843130","volume-title":"Applied Multivariate Statistics for the Social Sciences","author":"Stevens","year":"2012"},{"key":"zoi230496r1","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 National Survey on Drug Use and Health. 2021. Accessed April 26, 2023. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35325\/NSDUHFFRPDFWHTMLFiles2020\/2020NSDUHFFR1PDFW102121.pdf"},{"key":"zoi230496r3","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2020 National Survey on Drug Use and Health: detailed tables. 2021. Accessed April 26, 2023. https:\/\/www.samhsa.gov\/data\/report\/2020-nsduh-detailed-tables"},{"key":"zoi230496r17","unstructured":"Saxon? AJ. Screening for unhealthy use of alcohol and other drugs in primary care. UpToDate. February 16, 2022. Accessed April 26, 2023. https:\/\/www.uptodate.com\/contents\/screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care"},{"key":"zoi230496r32","unstructured":"NIH Style Guide. Race and national origin. National Institutes of Health. Accessed April 28, 2023. https:\/\/www.nih.gov\/nih-style-guide\/race-national-origin"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2805323\/matson_2023_oi_230496_1684340567.28141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T15:32:12Z","timestamp":1685115132000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2805323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16283","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]}}}